Revenue
2022
2023
2024
2025
Cellectar Biosciences, Inc. (CLRB)
Price$2.37Cached quote
Net income
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $11.5M | $26.1M | $27.3M | $18.3M | $17.6M | $10.1M | $9.0M | $6.8M | $9.5M | $4.8M | $5.2M | $6.0M | $6.9M | $5.1M | $3.6M | $3.0M | — | — | — | — | — | — | — |
| Operating expenses | $23.0M | $51.8M | $39.0M | $28.8M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | −$23.0M | −$51.8M | −$39.0M | −$28.8M | −$24.1M | −$15.3M | −$14.2M | −$13.3M | −$13.6M | −$9.4M | −$8.8M | −$9.9M | −$12.4M | −$8.8M | −$7.0M | −$4.2M | — | — | — | — | — | — | — |
| EBITDA | −$22.8M | −$51.5M | −$38.8M | −$28.7M | −$24.0M | −$15.1M | −$14.0M | −$13.2M | −$12.1M | −$9.1M | −$8.4M | −$9.5M | −$12.0M | −$8.3M | −$6.5M | −$3.6M | — | — | — | — | — | — | — |
| Net income | −$21.8M | −$44.6M | −$42.8M | −$31.8M | −$24.1M | −$15.1M | −$14.1M | −$13.2M | −$13.6M | −$6.2M | −$5.5M | −$8.1M | −$10.8M | −$8.8M | −$7.4M | −$4.6M | −$6.2M | −$6.1M | −$5.1M | −$963,440 | −$481,837 | −$342,761 | −$295,790 |
| Basic EPSper basic share | -$8.35 | -$36.52 | -$2,921,779.78 | -$3,764,921.95 | -$3,631,354.87 | -$6,344,436.10 | -$15,360,213.71 | -$43,659,737.87 | -$89,322,981.88 | -$178,645,963.77 | -$586,860,338.93 | -$1,463,394,273.31 | -$3,222,305,701.64 | -$3,840,053,426.83 | -$5,175,724,183.99 | -$6,010,518,407.21 | — | — | — | — | — | — | — |
| Diluted EPSper diluted share | -$8.35 | -$41.89 | -$2,921,779.78 | -$3,764,921.95 | -$3,631,354.87 | -$15,360,213.71 | -$15,360,213.71 | -$43,659,737.87 | -$89,322,981.88 | -$178,645,963.77 | -$586,860,338.93 | -$1,463,394,273.31 | -$3,222,305,701.64 | -$3,840,053,426.83 | -$5,175,724,183.99 | -$6,010,518,407.21 | — | — | — | — | — | — | — |
Owners
Reported shareholders
5.70%of listed shares
Caligan Partners LP470K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Caligan Partners LP | 5.70%470K shares |
Nantahala Capital Management, LLC | 5.33%440K shares |
STEMPOINT CAPITAL LP | 4.30%354.94K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.97%327.37K shares |
SILVERARC CAPITAL MANAGEMENT, LLC | 3.90%321.73K shares |
Bleichroeder LP | 3.50%288.68K shares |
Jupiter Topco LLC | 3.32%274.16K shares |
Balyasny Asset Management L.P. | 2.67%220K shares |
Empery Asset Management, LP | 2.30%189.61K shares |
DIADEMA PARTNERS LP | 1.68%138.34K shares |
Stonepine Capital Management, LLC | 1.27%104.55K shares |
Persistent Asset Partners Ltd | 1.13%92.98K shares |
BOOTHBAY FUND MANAGEMENT, LLC | 1.03%85.07K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.65%53.35K shares |
VANGUARD FIDUCIARY TRUST CO | 0.56%46.22K shares |
Sequoia Financial Advisors, LLC | 0.26%21.85K shares |
Longcor Jarrod | ≈0.25%20.45K shares |
CARUSO JAMES V | ≈0.25%20.32K shares |
ACADIAN ASSET MANAGEMENT LLC | 0.20%16.58K shares |
NORTHERN TRUST CORP | 0.18%14.84K shares |
Percentages use 8.25M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 7, 2026Form 4 | Longcor JarrodChief Operating Officer | BuyCommon Stock | 8.7K | $2.88 | $25.0K | 20.5K |
| May 7, 2026Form 4 | Longcor JarrodChief Operating Officer | BuyWarrants · derivative | 26.0K | $0.01 | $260.40 | 36.1K |
| May 7, 2026Form 4 | CARUSO JAMES VChief Executive Officer | BuyCommon Stock | 8.7K | $2.88 | $25.0K | 20.3K |
| May 7, 2026Form 4 | CARUSO JAMES VChief Executive Officer | BuyWarrants · derivative | 26.0K | $0.01 | $260.40 | 36.1K |
| Dec 12, 2025Form 4 | NEIS JOHNDirector | SellCommon Stock · indirect | 198 | $3.70 | $732.60 | 10 |